COVID-19 herd immunity: where are we?
- PMID: 32908300
- PMCID: PMC7480627
- DOI: 10.1038/s41577-020-00451-5
COVID-19 herd immunity: where are we?
Abstract
Herd immunity is a key concept for epidemic control. It states that only a proportion of a population needs to be immune (through overcoming natural infection or through vaccination) to an infectious agent for it to stop generating large outbreaks. A key question in the current COVID-19 pandemic is how and when herd immunity can be achieved and at what cost.
Conflict of interest statement
A.F. and S.C. are members of the COVID-19 Scientific Council advising the French Ministry of Health.
Similar articles
-
Not just antibodies: B cells and T cells mediate immunity to COVID-19.Nat Rev Immunol. 2020 Oct;20(10):581-582. doi: 10.1038/s41577-020-00436-4. Nat Rev Immunol. 2020. PMID: 32839569 Free PMC article.
-
Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry.Vaccine. 2020 Nov 10;38(48):7588-7595. doi: 10.1016/j.vaccine.2020.10.034. Epub 2020 Oct 13. Vaccine. 2020. PMID: 33097312 Free PMC article.
-
Cross-reactive memory T cells and herd immunity to SARS-CoV-2.Nat Rev Immunol. 2020 Nov;20(11):709-713. doi: 10.1038/s41577-020-00460-4. Epub 2020 Oct 6. Nat Rev Immunol. 2020. PMID: 33024281 Free PMC article. Review.
-
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice.Immunity. 2020 Oct 13;53(4):724-732.e7. doi: 10.1016/j.immuni.2020.07.019. Epub 2020 Jul 30. Immunity. 2020. PMID: 32783919 Free PMC article.
-
Immunological considerations for COVID-19 vaccine strategies.Nat Rev Immunol. 2020 Oct;20(10):615-632. doi: 10.1038/s41577-020-00434-6. Epub 2020 Sep 4. Nat Rev Immunol. 2020. PMID: 32887954 Free PMC article. Review.
Cited by
-
Effectiveness of Adapted COVID-19 Vaccines and Ability to Establish Herd Immunity against Omicron BA.1 and BA4-5 Variants of SARS-CoV-2.Vaccines (Basel). 2023 Dec 10;11(12):1836. doi: 10.3390/vaccines11121836. Vaccines (Basel). 2023. PMID: 38140240 Free PMC article.
-
Immune amnesia induced by measles and its effects on concurrent epidemics.J R Soc Interface. 2021 Jun;18(179):20210153. doi: 10.1098/rsif.2021.0153. Epub 2021 Jun 16. J R Soc Interface. 2021. PMID: 34129794 Free PMC article.
-
Modelling the Spread of the Coronavirus: A View from Economics.Aust Econ Rev. 2021 Mar;54(1):36-56. doi: 10.1111/1467-8462.12407. Epub 2021 Jan 27. Aust Econ Rev. 2021. PMID: 33821016 Free PMC article.
-
Comparative analysis of within-host diversity among vaccinated COVID-19 patients infected with different SARS-CoV-2 variants.iScience. 2022 Nov 18;25(11):105438. doi: 10.1016/j.isci.2022.105438. Epub 2022 Oct 25. iScience. 2022. PMID: 36310647 Free PMC article.
-
COVID-19 symptom relationship to antibody response and ACE2 neutralization in recovered health systems employees before and after mRNA BNT162b2 COVID-19 vaccine.PLoS One. 2022 Sep 9;17(9):e0273323. doi: 10.1371/journal.pone.0273323. eCollection 2022. PLoS One. 2022. PMID: 36083883 Free PMC article.
References
-
- Byambasuren O, et al. Estimating the seroprevalence of SARS-CoV-2 infections: systematic review. medRxiv. 2020 doi: 10.1101/2020.07.13.20153163. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical